Tele: 561.316.3330
Breaking Medical Device News

Wednesday, October 20, 2021

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR
HomeFDAApplied BioCode Obtains FDA Clearance of the Roche MagNA Pure 96 Extraction...

Applied BioCode Obtains FDA Clearance of the Roche MagNA Pure 96 Extraction System for its Gastrointestinal Pathogen Panel

Applied BioCode announced today that it has received U.S. Food and Drug Administration 510(k) clearance for the use of the Roche MagNA Pure 96* Extraction System with the high throughput BioCode® MDx-3000 and Gastrointestinal Pathogen Panel (GPP).

The BioCode® Gastrointestinal Pathogen Panel and BioCode® MDx-3000 System recently received U.S. Food and Drug Administration 510(k) clearance, using the bioMerieux NUCLISENS® easyMAG® extraction system. Now, with the addition of the MagNA Pure 96 System, Applied BioCode will have access to higher volume laboratories that utilize the Roche system for sample extraction. The MagNA Pure 96 System can extract DNA/RNA from up to 96 patient samples in approximately 60 minutes. The combination of the BioCode® MDx-3000 system and the Roche MagNA Pure 96 System will allow laboratories to easily process up to 188 patient samples in a single, 8-hour shift.

The comprehensive BioCode® Gastrointestinal Pathogen Panel provides results for the 17 most common bacteria, viruses, and parasites that cause infectious diarrhea. The panel includes targets for bacteria: Campylobacter (C. jejuni and C. coli), Clostridium difficile toxin A&B, Salmonella spp., Shigella/Enteroinvasive E. coli, Shiga-like toxin producing E.coli, E. coli O157, Enterotoxigenic E.coli, Enteroaggregative E. coli, Vibrio parahaemolyticus, Vibrio spp. (including Vibrio vulnificus and Vibrio cholerae), Yersinia enterocolitica, viruses: norovirus group I/II, adenovirus 40/41, rotavirus A, and parasites: Giardia lamblia, Cryptosporidium (C. hominis and C. parvum), Entamoeba histolytica.

The BioCode® MDx-3000 system offers the high volume laboratory an alternative to high cost, single use, cartridge-based molecular test systems. This user-friendly automated system also offers target masking capabilities within panels to address variation in test ordering patterns and potential changes in panel reimbursement. The BioCode® MDx-3000 system has the capability to process up to 3 different multiplex panels on the same run. It also offers a User Defined Mode where laboratories can develop their own multiplex assays to run on the system.

The BioCode® Gastrointestinal Pathogen Panel was the first of many syndromic infectious disease panels developed for the BioCode® MDx-3000 System. Applied BioCode also has a 20-plex Respiratory Pathogen Panel** completing Clinical Trials for the US market.

* The MagNA Pure 96 System is a product of F. Hoffmann-La Roche Ltd.
** In clinical trial, has not been cleared by the FDA.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Adam S. Epstein New CEO of AliMed, Inc.

In his prior role as Chief Commercial Officer, Epstein directed all customer-facing, demand generation and product development activities. Under his new leadership, AliMed will continue to build a robust portfolio of contracted positions with major, national GPO’s, IDN’s, and Distribution partners to drive sales growth.

Tony Collins Appointed CFO of Xenter

“Xenter is building a platform for medical innovations that is transformational. The only way we can achieve our objectives is if we have great leaders like Tony Collins leading our company,” stated Richard J. Linder, Founder, Chairman & CEO of Xenter, Inc. “Tony brings incredible depth and experience to his new role as Chief Financial Officer.

Scott Sexton Appointed President at FIGUR8

"Scott brings to FIGUR8 30 years of workers' compensation, casualty, disability, and commercial health experience, most recently serving as a market leader for CorVel's national carrier practice sales team," said Nan-Wei Gong, CEO, and co-founder of FIGUR8.

Insulet Announces Board of Director Changes with Appointment of Luciana Borio, M.D. and Retirement of Sally W. Crawford

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced...

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

By using this website you agree to accept Medical Device News Magazine Privacy Policy